ID
45297
Beskrivning
Principal Investigator: James Brugarolas, MD, PhD, UT Southwestern Medical Center, Dallas, TX, USA MeSH: Carcinoma, Renal Cell,Urogenital Neoplasms,Urologic Diseases https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000491 Study to evaluate the molecular genetics of ccRCC through integrative analyses of tumors and tumorgrafts using multiple platforms in clinically annotated samples. Genome and exome data for patients giving consent to have the information available on a public, secure, database is being submitted.
Länk
Nyckelord
Versioner (2)
- 2022-10-15 2022-10-15 - Chiara Middel
- 2022-10-17 2022-10-17 - Dr. Christian Niklas
Rättsinnehavare
James Brugarolas, MD, PhD, UT Southwestern Medical Center, Dallas, TX, USA
Uppladdad den
17 oktober 2022
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000491 Whole-Genome and Exome Sequencing in Clear-Cell Renal Cell Carcinoma
This data table contains subject IDs, consent group information and affection status.
- StudyEvent: SEV1
- This data table contains subject IDs, consent group information and affection status.
- The data table contains mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes a mapping of sample IDs to other sample ID aliases and sample use (SNP_Array, WES_SRA, WGS_SRA, and totRNA_Expression).
- The subject phenotype data table includes sociodemography variables (n=2; age and race), disease status (n=2; disease and onset age), tumor stage and grade (n=3), and presence or absence of somatic mutations (n=3; BAP1, PBRM1, VHL).
- The sample attributes data table includes sample type, body site where sample was extracted, sample analyte type and histological type. Tumor samples have further information relating to the stage, grade, location, and if tumor sample was primary or metastatic.
- The data table contains a mapping of sample IDs to GEO accessions.
Similar models
This data table contains subject IDs, consent group information and affection status.
- StudyEvent: SEV1
- This data table contains subject IDs, consent group information and affection status.
- The data table contains mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes a mapping of sample IDs to other sample ID aliases and sample use (SNP_Array, WES_SRA, WGS_SRA, and totRNA_Expression).
- The subject phenotype data table includes sociodemography variables (n=2; age and race), disease status (n=2; disease and onset age), tumor stage and grade (n=3), and presence or absence of somatic mutations (n=3; BAP1, PBRM1, VHL).
- The sample attributes data table includes sample type, body site where sample was extracted, sample analyte type and histological type. Tumor samples have further information relating to the stage, grade, location, and if tumor sample was primary or metastatic.
- The data table contains a mapping of sample IDs to GEO accessions.